Uncover key drivers, emerging technologies, and competitive movements shaping the medical imaging reconstruction artificial intelligence (ai) market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market show for the 2026–2030 period?
The market size for benign prostatic hyperplasia (bph) treatment devices and equipment has shown strong expansion in recent years. It is anticipated to grow from $1.34 billion in 2025 to $1.43 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.3%. Historically, this growth can be attributed to the rising prevalence of benign prostatic hyperplasia, increased awareness regarding urological disorders, the adoption of transurethral procedures, the expansion of urology departments in hospitals, and improvements in endoscopic surgical tools.
The benign prostatic hyperplasia (bph) treatment devices and equipment market size is projected to experience robust expansion over the coming years. It is anticipated to grow to $1.86 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.9%. This projected growth during the forecast period is attributable to an expanding aging male population, a heightened preference for minimally invasive therapies, the proliferation of outpatient urology clinics, increased adoption of laser and implant-based treatments, and a greater emphasis on reducing hospital stays. Significant trends within the forecast period encompass a rising uptake of minimally invasive bph treatment devices, the growing use of laser-based prostate therapies, an increasing demand for implant-based treatment options, the expansion of office-based bph procedures, and an enhanced focus on patient comfort and recovery.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
What Drivers Are Shaping The Development Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The benign prostatic hyperplasia market is anticipated to grow due to the increasing number of prostate cancer cases. Prostate cancer is a malignancy that develops in the prostate gland, a small, walnut-sized organ located just beneath the bladder in males. A rise in prostate cancer diagnoses frequently leads more elderly men to seek medical evaluation for prostate-related conditions, which in turn facilitates the identification and management of benign prostatic hyperplasia. For illustration, according to information from February 2023, provided by the American Society of Clinical Oncology (ASCO), a US-based professional organization that publishes patient details on the cancer.net website, an estimated 288,300 men in the United States had prostate cancer in 2023, while 268,490 new cases and 34,500 deaths from prostate cancer were reported in 2022. Therefore, the growing incidence of prostate cancer cases is a key driver for the benign prostatic hyperplasia market’s expansion.
Which Segments Are Contributing To The Growth Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Specialty Urology Centers
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
How Are New Market Trends Shaping The Landscape Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
Leading companies in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are focusing on developing innovative, minimally invasive solutions, such as temporarily implantable devices, which expand access to outpatient treatment and reduce reliance on long-term medication or tissue-removal procedures. These temporarily implantable BPH devices are single-use or short-term implants designed to reshape the prostatic urethra and relieve lower urinary tract symptoms (LUTS) caused by an enlarged prostate. For instance, in February 2025, Olympus, a Japan-based medical technology company, announced a milestone for its iTind device with expanded availability across major APAC markets (Thailand, Australia, Hong Kong, Singapore, India and a planned launch in Korea), highlighting that the iTind procedure is a minimally invasive, clinic-room option that can be performed under local anaesthesia and supported by a comprehensive physician training programme to aid clinical adoption. The iTind is a temporarily implantable nitinol device that reshapes the prostatic urethra to improve urinary flow and patient quality of life, and recent guideline and reimbursement developments are helping accelerate its adoption.
Who Are The Top-Performing Companies In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In Recent Years?
Major companies operating in the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2025. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp
Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2026, By The Business Research Company
Drugs For Benign Prostatic Hypertrophy Global Market Report 2026
Prostate Cancer Drugs Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company